---
category: news
title: "Topline results expected in mid-2020"
excerpt: "A non-invasive therapy that causes rapid symptom relief and de-escalates agitation may be ... About BioXcel Therapeutics, Inc. BioXcel Therapeutics, Inc. is a clinical stage biopharmaceutical company utilizing artificial intelligence to identify improved therapies in neuroscience and immuno-oncology. BTI's drug re-innovation approach leverages ..."
publishedDateTime: 2019-12-30T12:00:00Z
sourceUrl: https://www.globenewswire.com/news-release/2019/12/30/1964887/0/en/BioXcel-Therapeutics-Announces-Initiation-of-Pivotal-Phase-3-Studies-of-BXCL501-for-Acute-Treatment-of-Agitation-in-Patients-with-Schizophrenia-and-Bipolar-Disorder.html
type: article
quality: 4
heat: 4
published: false

provider:
  name: GlobeNewswire
  domain: globenewswire.com

topics:
  - AI
  - AI in Healthcare

secured: "BvycqtwcvHa9lz/MnO/Q8ddV8se7jI2YiJrdhUIyJvysiMl9L1eK2A2Oh9w3bnFqrmdjMEgxW+JAkPYv1vFvAr1R0AlR9gNQgF9VDu2cZxWaTw6dVEn161KEpZYP6NzFAVpTpjlArcQSO2JsdXaTBIPmtIWybQMqZMgs8zs5dBCGC/kHYPPSTDwJ5gZaUDykmuPnegWQTA0V06FPV07zqr50w5MtzTT9nkcOOu+hVIUBaCqkalEngSmN9Nu4uFG5MIuyxP3FoBQpb1jk/XxCCw==;Dok+ZW0rYl/0CxDqy8GKyg=="
---

